We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPRO icon
1001
GoPro
GPRO
$121M
$148K 0.01%
69,960
-117,960
-63% -$175K
AMPX icon
1002
Amprius Technologies
AMPX
$1.73B
$147K 0.01%
+14,018
New +$110K
LZ icon
1003
LegalZoom.com
LZ
$973M
$147K 0.01%
14,185
+1,470
+12% +$14.7K
EFXT
1004
Enerflex
EFXT
$2.5B
$147K 0.01%
+13,599
New +$126K
LNSR icon
1005
LENSAR
LNSR
$73.9M
$145K 0.01%
+11,706
New +$149K
GRAB icon
1006
Grab
GRAB
$15B
$144K 0.01%
23,889
-42,841
-64% -$227K
CRGY icon
1007
Crescent Energy
CRGY
$4.03B
$142K 0.01%
+15,952
New +$145K
TAL icon
1008
TAL Education Group
TAL
$6.93B
$142K 0.01%
+12,683
New +$137K
XNCR icon
1009
Xencor
XNCR
$1.6B
$139K 0.01%
+11,880
New +$103K
NUS icon
1010
Nu Skin
NUS
$250M
$139K 0.01%
11,404
-96
-0.8% -$1.01K
EVH icon
1011
Evolent Health
EVH
$444M
$139K 0.01%
+16,420
New +$159K
LODE icon
1012
Comstock
LODE
$247M
$139K 0.01%
+40,601
New +$127K
AMRX icon
1013
Amneal Pharmaceuticals
AMRX
$5.71B
$138K 0.01%
13,801
-24,322
-64% -$218K
UEIC icon
1014
Universal Electronics
UEIC
$71.6M
$136K 0.01%
29,161
+13,705
+89% +$75.4K
CCCX
1015
DELISTED
Churchill Capital Corp X
CCCX
$135K 0.01%
+10,528
New +$111K
HTZ icon
1016
Hertz
HTZ
$756M
$134K 0.01%
+19,726
New +$127K
F icon
1017
Ford
F
$55.8B
$133K 0.01%
11,109
-37,310
-77% -$430K
BIVIW
1018
BioVie Inc Warrant
BIVIW
$64K
$132K 0.01%
+293,436
New +$119K
DBI icon
1019
Designer Brands
DBI
$334M
$131K 0.01%
37,000
– –
LUMN icon
1020
Lumen
LUMN
$6.85B
$130K 0.01%
+21,322
New +$102K
EHAB
1021
DELISTED
Enhabit
EHAB
$129K 0.01%
16,055
-200
-1% -$1.5K
XERS icon
1022
Xeris Biopharma Holdings
XERS
$1.46B
$126K 0.01%
15,500
– –
RBBN icon
1023
Ribbon Communications
RBBN
$367M
$125K 0.01%
32,838
+9,100
+38% +$35.8K
PRME icon
1024
Prime Medicine
PRME
$571M
$125K 0.01%
22,483
-18,805
-46% -$76.4K
CURI icon
1025
CuriosityStream
CURI
$166M
$121K 0.01%
22,900
-1,500
-6% -$6.91K
39 40
41
42 43

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.